Seeing Is Believing
Currently out of the existing stock ratings of Mohan Naidu, 68 are a BUY (95.77%), 3 are a HOLD (4.23%).
Analyst Mohan Naidu, carries an average stock price target met ratio of 82.18% that have a potential upside of 31.32% achieved within 580 days.
Mohan Naidu’s has documented 152 price targets and ratings displayed on 12 stocks. The coverage was on Healthcare, Technology sectors.
Most recent stock forecast was given on EVH, Evolent Health at 18-Nov-2024.
Analyst best performing recommendations are on TRHC (TABULA RASA HEALTHCARE).
The best stock recommendation documented was for OMCL (OMNICELL) at 10/26/2018. The price target of $73 was fulfilled within 12 days with a profit of $8.5 (13.18%) receiving and performance score of 10.98.
Average potential price target upside
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date
Price targets met ratio
Average potential upside
Average Time (Days) For PT To Be Met
Performance score
Buy
$125
$15.24 (13.88%)
$110
7 days ago
(26-Feb-2025)
9/10 (90%)
$19.39 (18.36%)
545
Buy
$105
$-4.76 (-4.34%)
$100
2 months 23 days ago
(10-Dec-2024)
12/12 (100%)
$9.61 (10.07%)
226
Buy
$107
$-2.76 (-2.51%)
$105
2 months 23 days ago
(10-Dec-2024)
4/4 (100%)
$11.61 (12.17%)
163
Buy
$120
$10.24 (9.33%)
$105
3 months 3 days ago
(02-Dec-2024)
18/19 (94.74%)
$18.34 (18.04%)
194
Buy
$130
$20.24 (18.44%)
$110
3 months 19 days ago
(14-Nov-2024)
2/3 (66.67%)
$34.3 (35.84%)
558
Which stock is Mohan Naidu is most bullish on?
What Year was the first public recommendation made by Mohan Naidu?